Ardelyx is a publicly traded commercial biopharmaceutical company founded with a mission to discover, develop and commercialize innovative first-in-class medicines that meet significant unmet medical needs. Ardelyx has two commercial products approved in the United States, IBSRELA® (tenapanor) and XPHOZAH® (tenapanor). Ardelyx has agreements for the development and commercialization of tenapanor outside of the U.S. Kyowa Kirin commercializes PHOZEVEL® (tenapanor) for hyperphosphatemia in Japan. A New Drug Application for tenapanor for hyperphosphatemia has been approved in China with Fosun Pharma. Knight Therapeutics commercializes IBSRELA in Canada. Position Summary: Reporting directly to the Corporate Development and Strategy Manager, the Corporate Development Transactions Intern will gain hands-on experience in biopharmaceutical corporate development and the steps involved in executing strategic transactions. The intern will learn to use market intelligence and financial databases to interpret large datasets, analyze the financials and strategies of potential targets, and develop recommendations that inform future corporate development activities. This role will also support ad hoc projects, providing exposure to business, finance, and scientific analysis in a biopharma setting.
Stand Out From the Crowd
Upload your resume and get instant feedback on how well it matches this job.
Career Level
Intern
Education Level
No Education Listed
Number of Employees
101-250 employees